Not applicableNo Longer AvailableNCT04678466What this trial is testingFlotetuzumab Expanded Access ProgramWho this might be right forAcute Myeloid LeukemiaAMLAML, Adult Recurrent MacroGenics
Not applicableUnknownNCT05873322What this trial is testingGlucose Intolerance and Diabetes Related to Treatment With Steroids and PEG- Asparaginase in Children and Adolescents With ALL and LymphomaWho this might be right forPrecursor Cell Lymphoblastic Leukemia-LymphomaDrug-Induced Diabetes MellitusImpaired Glucose Tolerance+1 more Aarhus University Hospital 100
Not applicableStudy completedNCT06061302What this trial is testingMultiple Myeloma Yoga Pilot StudyWho this might be right forMultiple Myeloma University of Arizona 31
Testing effectiveness (Phase 2)Looking for participantsNCT06087653What this trial is testingSafety, Efficacy, and Pharmacokinetics of Continuous Subcutaneous Lenalidomide in Multiple Myeloma (MM)Who this might be right forMultiple Myeloma Starton Therapeutics, Inc 24
Testing effectiveness (Phase 2)Ended earlyNCT03340883What this trial is testingSafety and Tolerability of BION-1301 in Adults With Relapsed or Refractory Multiple Myeloma (MM)Who this might be right forMultiple Myeloma Chinook Therapeutics, Inc. 21
Early research (Phase 1)Looking for participantsNCT06634394What this trial is testingAPVO436 Phase 1b/2 Study in Patients With Newly Diagnosed AMLWho this might be right forAcute Myeloid Leukemia (AML) Aptevo Therapeutics 39
Not applicableLooking for participantsNCT05706766What this trial is testingPrehabilitation Exercise Training in Multiple Myeloma Patients Undergoing Autologous Stem Cell TransplantationWho this might be right forMultiple MyelomaStem Cell Transplant Complications Dana-Farber Cancer Institute 30
Not applicableStudy completedNCT01675102What this trial is testingAllogeneic Hematopoietic Stem Cell Transplantation (HSCT) in 17p- Chronic Lymphocytic Leukemia (CLL)Who this might be right forCLL European Society for Blood and Marrow Transplantation 41
Testing effectiveness (Phase 2)WithdrawnNCT04629651What this trial is testingCaptopril Use on the Degree of Marrow Fibrosis in Bone Marrow Fibrosis/Myeloproliferative NeoplasmsWho this might be right forBone Marrow FibrosisMyeloproliferative Neoplasm Case Comprehensive Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00810602What this trial is testingVorinostat to Prevent Graft Versus Host Disease Following Reduced Intensity, Related Donor Stem Cell TransplantWho this might be right forHematologic MalignanciesGraft vs Host Disease Pavan Reddy, MD 61
Testing effectiveness (Phase 2)Study completedNCT00083694What this trial is testingThalidomide Anti-Angiogenesis Therapy of Relapsed or Refractory LeukemiaWho this might be right forLeukemia University of Arkansas 25
Testing effectiveness (Phase 2)Looking for participantsNCT03589729What this trial is testingDexrazoxane Hydrochloride in Preventing Heart-Related Side Effects of Chemotherapy in Participants With Blood CancersWho this might be right forAcute Myeloid LeukemiaBlast Phase Chronic Myelogenous Leukemia, BCR-ABL1 PositiveBlasts 10 Percent or More of Bone Marrow Nucleated Cells+4 more M.D. Anderson Cancer Center 100
Testing effectiveness (Phase 2)Study completedNCT00793572What this trial is testingAutologous or Syngeneic Stem Cell Transplant Followed by Donor Stem Cell Transplant and Bortezomib in Treating Patients With Newly Diagnosed High-Risk, Relapsed, or Refractory Multiple MyelomaWho this might be right forRefractory Plasma Cell Myeloma Fred Hutchinson Cancer Center 32
Testing effectiveness (Phase 2)Study completedNCT04542356What this trial is testingStudy on the Efficacy and Safety of PEG-rhG-CSF in Preventing Neutropenia During Concurrent Chemoradiotherapy of Cervical CancerWho this might be right forCervical Cancer Chongqing University Cancer Hospital 60
Large-scale testing (Phase 3)Study completedNCT02472145What this trial is testingAn Efficacy and Safety Study of Decitabine (DACOGEN) Plus Talacotuzumab (JNJ-56022473; Anti CD123) Versus Decitabine (DACOGEN) Alone in Participants With Acute Myeloid Leukemia (AML) Ineligible for Intensive ChemotherapyWho this might be right forLeukemia, Myeloid, Acute Janssen Research & Development, LLC 326
Large-scale testing (Phase 3)Active Not RecruitingNCT01886872What this trial is testingRituximab and Bendamustine Hydrochloride, Rituximab and Ibrutinib, or Ibrutinib Alone in Treating Older Patients With Previously Untreated Chronic Lymphocytic LeukemiaWho this might be right forStage I Chronic Lymphocytic LeukemiaStage II Chronic Lymphocytic LeukemiaStage III Chronic Lymphocytic Leukemia+1 more National Cancer Institute (NCI) 547
Not applicableStudy completedNCT03099031What this trial is testingNon Interventional Study of the Validation of the Ottawa Score in Cancer Patients With Venous Thromboembolism (VTE)Who this might be right forVenous Thromboembolism LEO Pharma 420
Not applicableStudy completedNCT04872621What this trial is testingCalquence CLL rr Japan PMS_Japan Post-Marketing Surveillance (PMS) Study - All Patient InvestigationWho this might be right forRelapsed or Refractory Chronic Lymphocytic Leukemia (Including Small Lymphocytic Lymphoma) AstraZeneca 104
Large-scale testing (Phase 3)Study completedNCT01910987What this trial is testingStudy to Evaluate Optimized Retreatment and Prolonged Therapy With BortezomibWho this might be right forMultiple Myeloma Janssen-Cilag International NV 80
Not applicableStudy completedNCT05045963What this trial is testingImpact of Aminoglycosides in Hypotensive Septic Oncology PatientsWho this might be right forHematopoietic and Lymphoid Cell NeoplasmMalignant Solid NeoplasmSepticemia M.D. Anderson Cancer Center 232